The Network of Services for COVID-19 Vaccination in Persons With Mental Disorders: The Italian Social Health System, Its Organization, and Bioethical Issues.
COVID-19 vaccination
ethics
good practices
health services
healthcare system
mental disorders
vaccine hesitancy
Journal
Frontiers in public health
ISSN: 2296-2565
Titre abrégé: Front Public Health
Pays: Switzerland
ID NLM: 101616579
Informations de publication
Date de publication:
2022
2022
Historique:
received:
11
02
2022
accepted:
31
05
2022
entrez:
7
7
2022
pubmed:
8
7
2022
medline:
9
7
2022
Statut:
epublish
Résumé
The adoption of restrictive measures aimed at curtailing the spread of SARS-CoV2 has had a harmful impact on socio-affective relationships, while limiting the scope of interventions and activities to promote social inclusion, with considerable negative repercussions for patients with mental disorders. Vaccination has been and will continue to be a valid tool to overcome the barriers of social isolation and to protect the health of this category of patients. In this paper we present an overview of the Italian network of social and healthcare services for COVID-19 vaccination among patients with mental disorders. Some aspects of medical ethics are discussed in order to share good practices for improving the health of this vulnerable group of people. We then consider the measures implemented by the health system in Italy to deal with the phenomenon of vaccine hesitancy before addressing the issue of autonomy and restricted access to vaccination points. Finally, we illustrate some of the perspectives already adopted by the Italian system, which may be useful to the global scientific community.
Identifiants
pubmed: 35795707
doi: 10.3389/fpubh.2022.870386
pmc: PMC9252269
doi:
Substances chimiques
COVID-19 Vaccines
0
RNA, Viral
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
870386Informations de copyright
Copyright © 2022 Scendoni, Fedeli and Cingolani.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Psychiatry Res. 2020 Sep;291:113265
pubmed: 32763536
Vaccines (Basel). 2021 Apr 24;9(5):
pubmed: 33923367
J Nerv Ment Dis. 2021 Dec 1;209(12):884-891
pubmed: 34710895
Ann Ist Super Sanita. 2018 Oct-Dec;54(4):272-283
pubmed: 30575563
Front Psychiatry. 2021 Dec 16;12:805528
pubmed: 34975599
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Lancet. 2021 Jan 2;397(10268):8-10
pubmed: 33308484
J Am Psychiatr Nurses Assoc. 2020 Mar/Apr;26(2):172-180
pubmed: 30866701
J Med Ethics. 2003 Feb;29(1):41-3
pubmed: 12569195
Acta Neuropsychiatr. 2021 Oct;33(5):273-276
pubmed: 33998428
Int J Environ Res Public Health. 2021 Dec 21;19(1):
pubmed: 35010289
Vaccine. 2015 Aug 14;33(34):4161-4
pubmed: 25896383
Lancet Psychiatry. 2021 Apr;8(4):275-276
pubmed: 33743876
BMJ. 2020 Apr 29;369:m1609
pubmed: 32349992
Vaccine. 2014 Apr 17;32(19):2150-9
pubmed: 24598724
Int J Soc Psychiatry. 2022 Mar 07;:207640221081801
pubmed: 35253527
JAMA Psychiatry. 2021 Apr 1;78(4):380-386
pubmed: 33502436
Eur Neuropsychopharmacol. 2022 Jan;54:90-99
pubmed: 34607722
Lancet Psychiatry. 2021 May;8(5):444-450
pubmed: 33548184
Front Public Health. 2022 Jan 07;9:799812
pubmed: 35071173
EClinicalMedicine. 2021 Oct;40:101111
pubmed: 34514362
Lancet Psychiatry. 2021 Oct;8(10):860-861
pubmed: 34416185
Nat Commun. 2021 Jan 4;12(1):29
pubmed: 33397962
BMJ. 2021 Feb 26;372:n513
pubmed: 33637577
J Clin Med. 2021 Apr 01;10(7):
pubmed: 33916020
EClinicalMedicine. 2021 May;35:100854
pubmed: 33907730